Sandesh Seth, Director at Actinium Pharmaceuticals, Inc. (ATNM), bought 15,000 shares at $2.00 ($30K) on 2016-04-14, disclosed to the SEC on 2016-04-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.00 | 5,000 | $10K | 33.4% |
| 2 | $2.00 | 2,000 | $4K | 13.4% |
| 3 | $2.01 | 1,500 | $3K | 10.1% |
| 4 | $1.98 | 5,000 | $10K | 33.1% |
| 5 | $1.99 | 1,500 | $3K | 10.0% |
| Total | $1.99 avg | 15,000 |
| $30K |
| 100% |
| Filing → |
| ATNM | BUY | 2018-04-20 | $2K | — | Filing → |
| ATNM | BUY | 2017-08-04 | $25K | — | Filing → |
| ATNM | BUY | 2017-06-15 | $9K | — | Filing → |